Navigating early developmental care for newborns and toddlers can be daunting for parents, but catching challenges early can ...

These shares are avoiding the market weakness on Thursday. But why? The post Why Core Lithium, Healius, Neuren, and Reject ...

Let's see how the market has responded to these announcements. The post 2 ASX 200 biotech stocks announcing big news today ...

Neuren Pharmaceuticals (ASX:NEU) has announced it will develop its drug candidate NNZ-2591 to treat hypoxic-ischemic ...

Neuren Pharmaceuticals has announced it will develop a new drug to treat a type of life-threatening brain injury in infants, ...